Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Indomethacin and Oxytocin

supplement:

Oxytocin

Research Papers that Mention the Interaction

Oxytocin failed (P<0.001) to elicit PGF2α release in explants cultured with either Atosiban or indomethacin.
Animal reproduction science  •  2013  |  View Paper
However, the OT positive effect was not blocked by mifepristone (P4 antagonist), but was inhibited by indomethacin (a non-selective PTGS2 inhibitor).
Reproduction in domestic animals = Zuchthygiene  •  2013  |  View Paper
Pretreatment with systemic injection of the prostaglandin synthesis inhibitor indomethacin dose‐dependently reduced the oxytocin response and prevented the vasopressin response to histamine or LPS.
Journal of neuroendocrinology  •  2003  |  View Paper
These changes caused by oxytocin were prevented by indomethacin , a prostaglandin synthetase inhibitor, although indomethacin given alone did not affect luteal function.
Prostaglandins  •  1994  |  View Paper
Mepacrine, NDHG and indomethacin also inhibited tonic contractions by OT in calcium-free EDTA treated medium.
Mepacrine, NDHGA and indomethacin , but not imidazol, inhibited in a dose-dependent way contractions induced by OT in the uterus.
Methods and findings in experimental and clinical pharmacology  •  1991  |  View Paper
In contrast, OXY release in response to hemorrhage of either 22 or 44% of the blood volume of the rat was enhanced by indomethacin.
Indomethacin increased the hemorrhage-induced OXY levels about 2-fold over a 2-hour posthemorrhage period.
The paradoxical effects of indomethacin on OXY release suggest that the prostaglandins may have different effects on OXY release depending upon the evoking stimulus.
Neuroendocrinology  •  1986  |  View Paper
Daily subcutaneous administration of the prostaglandin synthetase inhibitor indomethacin (10 mg kg-1) between days 11 and 16, delayed luteolysis and suppressed both the decline in oxytocin concentrations and the pulsatile appearance of both oxytocin and PGFM in the peripheral circulation.
Research in veterinary science  •  1984  |  View Paper
2 Indomethacin , an inhibitor of cyclo‐oxygenase, did not reduce the response to angiotensin II but did abolish the contractile response to low doses of oxytocin.
British journal of pharmacology  •  1983  |  View Paper
4) In isolated uterine horns, the contractile response to OT was only slightly attenuated in the presence of indomethacin sufficient to inhibit completely the OT-stimulated PG synthesis.
The Journal of pharmacology and experimental therapeutics  •  1980  |  View Paper
Show More